Increase in Fixed-Cost Burdens from Upfront Development and Capital Expenditure
First written in FY2020-Q1. 7 of 14 entries say "Worsened", first in FY2020-Q2. Latest entry: FY2026.
Sanken Electric moved to the "Worse" side of this theme in 2019, the same year as the typical company in this theme.
The whole theme swung hardest in 2023: 8 of 16 companies on the "Worse" side.
4 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「The cost-of-sales ratio deteriorated by 11.2 percentage points from the previous consolidated fiscal year to 90.6%.」
The cost-of-sales ratio deteriorated by 11.2 percentage points due to lower sales following the reduction in the scope of consolidation and higher metal benchmark prices, among other factors. - 2026-05-15MitigatedEarnings presentation
「震災前の生産性を回復させ最適生産へ、リソース活用最大化」
先行開発・設備投資による固定費負担への対応として、震災前の生産性回復、最適生産、リソース活用最大化を進める方針が示された。 - FY2024-Q1MitigatedAnnual report
「As a result, consolidated net sales increased substantially to ¥59,906 million, up ¥10,273 million, or 20.7%, year on year. In terms of earnings, consolidated operating profit increased to ¥8,527 million, up ¥7,591 million, or 811.2%, year on year, due to higher sales and the absence this fiscal year of the one-time expense at a U.S. subsidiary recorded in the same quarter of the previous year,」
The disappearance of the one-time expense at the U.S. subsidiary recorded in the previous year, together with higher sales, drove operating profit up 811.2% year on year, easing the pressure on earnings from front-loaded investment and fixed costs in the quarter. - FY2023MitigatedAnnual report
「The cost-of-sales ratio improved by 5.7 percentage points from the previous consolidated fiscal year to 62.9%.」
Higher sales and improved productivity reduced the cost-of-sales ratio, which is affected by factory utilization and the fixed-cost burden, by 5.7 percentage points. - FY2022-Q3MitigatedAnnual report
「In terms of earnings, consolidated operating profit was ¥9,679 million, compared with a consolidated operating loss of ¥3,829 million in the same quarter of the previous year, due to higher sales.」
As sales increased with the market recovery, the company swung from an operating loss in the previous year to operating profit of ¥9,679 million, while the impact of factory utilization and the fixed-cost burden eased. - FY2022-Q1MitigatedAnnual report
「In terms of earnings, consolidated operating profit was ¥3,220 million, compared with a consolidated operating loss of ¥849 million in the same quarter of the previous year, due to higher sales.」
As sales increased with the market recovery, consolidated operating results improved from an operating loss in the previous year to profit of ¥3,220 million. - FY2021MitigatedAnnual report
「The cost-of-sales ratio improved by 1.0 percentage point from the previous consolidated fiscal year to 75.0%.」
The cost-of-sales ratio improved by 1.0 percentage point despite the fixed-cost and cost burden associated with lower sales and utilization. However, an operating loss was recorded due to IPO-related expenses and other factors. - FY2021-Q3WorsenedAnnual report
「In terms of earnings, although we implemented emergency measures including expense reductions, the result was a consolidated operating loss of ¥1,718 million, compared with consolidated operating profit of ¥4,242 million in the same quarter of the previous year.」
Despite implementing emergency measures, the semiconductor devices business deteriorated from operating profit in the previous year to an operating loss of ¥1,718 million. - FY2021-Q2WorsenedAnnual report
「Although we implemented measures including expense reductions in the semiconductor devices business, consolidated operating profit was ¥985 million, down ¥1,139 million, or 53.6%, year on year.」
Despite implementing expense-reduction measures, operating profit in the semiconductor devices business declined 53.6% year on year, and the impact of utilization and the fixed-cost burden continues. - FY2021-Q1WorsenedAnnual report
「In terms of earnings, we implemented emergency measures, including expense reductions, in response to the deterioration in earnings caused by lower sales resulting from the rapid deterioration in market conditions and lower factory utilization. However, consolidated operating profit was ¥126 million, down ¥320 million, or 71.7%, year on year.」
Lower sales due to deteriorating market conditions and lower factory utilization caused operating profit in the semiconductor devices business to decline 71.7% year on year, and the impact of utilization and the fixed-cost burden continues. - FY2020WorsenedAnnual report
「Cost of sales for the consolidated fiscal year was ¥121,768 million, down ¥4,381 million, or 3.5%, from the previous consolidated fiscal year, due to lower net sales and the resulting decline in factory utilization. The cost-of-sales ratio deteriorated by 3.4 percentage points from the previous consolidated fiscal year to 76.0%.」
The cost-of-sales ratio deteriorated by 3.4 percentage points due to lower sales and factory utilization, bringing the fixed-cost and utilization burden to the fore for the full fiscal year. - FY2020-Q3WorsenedAnnual report
「In terms of earnings, consolidated operating profit was ¥1,928 million, down ¥6,885 million, or 78.1%, year on year, due to lower factory utilization resulting from the decline in net sales.」
Lower factory utilization associated with reduced net sales caused operating profit to decline 78.1% year on year, making the impact of utilization and the fixed-cost burden increasingly clear. - FY2020-Q2WorsenedAnnual report
「In terms of earnings, consolidated operating profit was ¥291 million, down ¥6,028 million, or 95.4%, from the same quarter of the previous year, due to lower factory utilization resulting from the decline in net sales.」
Lower factory utilization associated with reduced net sales caused operating profit to decline 95.4% year on year, bringing the fixed-cost burden and utilization risk to the fore. - FY2020-Q1First statedAnnual report
「In terms of earnings, consolidated operating profit was ¥447 million, down ¥2,958 million, or 86.9%, year on year, due to lower sales, lower factory utilization, and a higher fixed-cost burden associated with front-loaded R&D and capital investment.」
The higher fixed-cost burden from front-loaded R&D and capital investment emerged as a factor behind the decline in operating profit, along with lower factory utilization and reduced sales.